Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
06 May 2022  |  North America
Growth Strategies to Boost Health Data Quality and Value
Frost & Sullivan has recognized remote patient monitoring as one of the top 5 trends in digital health investments. This report addresses how the Internet of Medical Things (IoMT) market offers significant growth opportunities in remote patient monitoring for all healthcare stakeholders and leading information and communication technology (ICT) com...
29 Apr 2022  |  Global
INNOVATIONS AND GROWTH OPPORTUNITIES IN NOVEL DIAGNOSTICS, MONITORING TECHNOLOGIES AND ADVANCED MEDICAL DEVICES
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes diagnostic and monitoring technologies such as point of care diagnostic for sexually transmitted disease, COVID-19 immunoassay, amplified lateral flow assay, SARS-CoV...$950.00
25 Apr 2022  |  North America
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...
25 Apr 2022  |  Global
Portable Mobile Imaging Devices, Technologies that Lower Dose Exposure, and the Use of Artificial Intelligence and Gamification will Revolutionize Pediatric Imaging.
Imaging is an important element in the clinical evaluation of pediatric patients, and it helps in better diagnosis and treatment of different medical conditions. However, pediatric patients are more radiosensitive than adults, and excessive radiation exposure puts them at risk of developing cancer. In addition, the imaging device settings used for ...
25 Apr 2022  |  North America
Transitional Care Delivery Models and Payer Policies Redefining Stakeholders’ Future Growth Strategies
The United States is the world’s largest healthcare market, spending over 18% of its GDP on healthcare. Therefore, it is important for healthcare stakeholders to understand how the US healthcare market functions, primarily its insurance system. The US health insurance landscape has seen significant evolution through various legislations, ranging ...
22 Apr 2022  |  Global
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights technology developments related to immunotherapies related to cancer and cell therapies. along with technology developments from universities focused on overcoming issues related to COVID-19. The issue also depicts innovations in the synthetic biology...$950.00
22 Apr 2022  |  Global
Exploration of New Clinical Applications Drive Future Growth Potential
Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute...
18 Apr 2022  |  North America
Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally
Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...
13 Apr 2022  |  North America
Transformational Growth with the Proposed Launch of ARPA-H to Spur Investments across High-risk, High-reward Translational Research Projects, Foster Breakthroughs, and Facilitate Equitable Access to Care
The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e.g., X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human heal...
04 Apr 2022  |  North America
Professional Services will Propel Future Growth for MVS Market Participants
The North American and European multi-vendor services (MVS) market is expected to witness significant changes over the next couple of years, driven by the increasing adoption of technology by both MVS providers and healthcare facilities, the shift from inpatient to outpatient settings for surgical procedures, and the rising use of medical equipment...